Tcw Group Inc Neogenomics Inc Transaction History

Tcw Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$12.15 - $35.28 $2.83 Million - $8.23 Million	-233,162 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$30.49 - $48.49 $1.01 Million - $1.61 Million	-33,150 Reduced 12.45%	233,162 $7.96 Million
Q3 2021 Oct 26, 2021	BUY	$41.66 - $52.52 $5.08 Million - $6.4 Million	121,946 Added 84.47%	266,312 $12.8 Million
Q2 2021 Jul 23, 2021	SELL	$36.62 - $51.69 $1.19 Million - $1.68 Million	-32,459 Reduced 18.36%	144,366 $6.52 Million
Q1 2021 May 05, 2021	SELL	$41.56 - $59.88 $1.55 Million - $2.24 Million	-37,375 Reduced 17.45%	176,825 $8.53 Million
Q4 2020 Feb 02, 2021	SELL	$36.08 - $56.47 $2.09 Million - $3.27 Million	-57,893 Reduced 21.28%	214,200 $11.5 Million
Q3 2020 Oct 30, 2020	SELL	$33.26 - $40.48 $1.76 Million - $2.14 Million	-52,972 Reduced 16.3%	272,093 $10 Million
Q2 2020 Aug 05, 2020	SELL	$24.21 - $31.02 $1,234 - $1,582	-51 Reduced 0.02%	325,065 $10.1 Million
Q1 2020 May 05, 2020	BUY	$20.5 - $34.53 $3.37 Million - $5.68 Million	164,502 Added 102.42%	325,116 $8.98 Million
Q4 2019 Feb 10, 2020	BUY	$18.96 - $29.84 $2.81 Million - $4.43 Million	148,297 Added 1204.0%	160,614 $4.7 Million
Q3 2019 Nov 13, 2019	BUY	$19.12 - $26.24 $235,501 - $323,198	12,317 New	12,317 $236,000

278

125M

581K

115K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.05B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.